(Joseph, 10/23) Stat: J&J Lung Cancer Data Amount To New Salvo Against AstraZeneca A competition has been brewing between two pharma titans — Johnson & Johnson and AstraZeneca — to gain an edge in the market for targeted lung cancer treatments. A primetime presentation here Monday amounted to the latest salvo. (Joseph, 10/23) Stat: Questions Loom On AstraZeneca Cancer Drug As Safety Concerns Ebb Questions about one of AstraZeneca's key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months. (Joseph, 10/23) Also — Reuters: Several People Taken To Hospital In Austria After Taking Suspected Fake Ozempic Several people were taken to hospital in Austria after using suspected counterfeits of the diabetes drug Ozempic, according to the federal health safety office.